Lancet

Risk and aetiology of diarrhoea at various tourist destinations.von Sonnenburg F, Tornieporth N, Waiyaki P, Lowe B, Peruski LF, DuPont HL, Mathewson JJ, Steffen R
Lancet, (2000). 356:133-4

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.Shretta R, Brugha R, Robb A, Snow RW
Lancet, (2000). 355:1718-20

Autoagglutination of malaria-infected red blood cells and malaria severity.Roberts DJ, Pain A, Kai O, Kortok M, Marsh K
Lancet, (2000). 355:1427-8

Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya.Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, Mandaliya K, Getambu E, Gleeson F, Drobniewski F, Marsh K
Lancet, (2000). 355:1225-30

Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, Winstanley P, Peto T, Marsh K
Lancet, (2000). 355:701-6

Averting a malaria disaster.White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P
Lancet, (1999). 353:1965-7

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K
Lancet, (1999). 353:632-6

Malaria disaster in Africa.Marsh K
Lancet, (1998). 352:924

Development of a malaria vaccine.Kwiatkowski D, Marsh K
Lancet, (1997). 350:1696-701

Malarone-donation programme in Africa.Bloland PB, Kazembe PN, Watkins WM, Doumbo OK, Nwanyanwu OC, Ruebush TK
Lancet, (1997). 350:1624-5

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa.Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, Weber MW, Pinder M, Nahlen B, Obonyo C, Newbold C, Gupta S, Marsh K
Lancet, (1997). 349:1650-4

Impact of UK malaria prophylaxis policy on imported malaria.Behrens RH, Bradley DJ, Snow RW, Marsh K
Lancet, (1996). 348:344-5

Chronic salicylate poisoning and severe malaria.English M, Marsh V, Amukoye E, Lowe B, Murphy S, Marsh K
Lancet, (1996). 347:1736-7

Clinical algorithm for malaria in Africa.Marsh K, English M, Peshu N, Crawley J, Snow R
Lancet, (1996). 347:1327-8; author reply 1328-9

Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya.Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, Batchelor BI, Kimari JN, Newnham R, Bwayo J, Plummer FA
Lancet, (1996). 347:718-23

Insecticide-treated bed nets in control of malaria in Africa.Snow RW, Lengeler C, de Savigny D, Cattani J
Lancet, (1995). 345:1056-7

Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity.Paul J, Kimari J, Gilks CF
Lancet, (1995). 346:1034-5

The clinical challenge of the HIV epidemic in the developing world.Gilks CF
Lancet, (1993). 342:1037-9

Patarroyo's vaccine.Marsh K
Lancet, (1993). 341:729-30

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.Hawken M, Nunn P, Gathua S, Brindle R, Godfrey-Faussett P, Githui W, Odhiambo J, Batchelor B, Gilks C, Morris J
Lancet, (1993). 342:332-7